SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-290314
Filing Date
2020-11-10
Accepted
2020-11-10 17:17:23
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d809345ds3.htm S-3 455416
2 EX-1.2 d809345dex12.htm EX-1.2 199795
3 EX-4.7 d809345dex47.htm EX-4.7 298563
4 EX-5.1 d809345dex51.htm EX-5.1 23727
5 EX-5.2 d809345dex52.htm EX-5.2 13052
6 EX-5.3 d809345dex53.htm EX-5.3 13562
7 EX-23.1 d809345dex231.htm EX-23.1 1970
8 GRAPHIC g809345dsp8latwat.jpg GRAPHIC 6771
9 GRAPHIC g809345g11i11.jpg GRAPHIC 53615
10 GRAPHIC g809345g59u79.jpg GRAPHIC 5040
  Complete submission text file 0001193125-20-290314.txt   1093075
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-250014 | Film No.: 201302183
SIC: 2834 Pharmaceutical Preparations